(Q53096709)

11 May 2018

title

Short- and long-term effects of the use of RAAS blockers immediately after renal transplantation. (English)

1 reference

11 May 2018

9

Hermann Haller

1 reference

11 May 2018

author name string

Christos Chatzikyrkou

1

1 reference

11 May 2018

Jenny Eichler

2

1 reference

11 May 2018

Annika Karch

3

1 reference

11 May 2018

Christian Clajus

4

1 reference

11 May 2018

Florian Gunnar Scurt

5

1 reference

11 May 2018

Wolf Ramackers

6

1 reference

11 May 2018

Frank Lehner

7

1 reference

11 May 2018

Jan Menne

8

1 reference

11 May 2018

Peter R Mertens

10

1 reference

11 May 2018

Mario Schiffer

11

1 reference

11 May 2018

publication date

19 May 2016

1 reference

11 May 2018

published in

Blood Pressure

1 reference

11 May 2018

volume

26

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

30-38

1 reference

11 May 2018

Improved long-term outcomes after renal transplantation associated with blood pressure control

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

US Renal Data System 2010 Annual Data Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Pathogenesis and management of hypertension after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Angiotensin II blockade in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Normotensive ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Acute kidney injury and cardiovascular outcomes in acute severe hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Diabetic kidney disease with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08037051.2016.1182856

10.1080/08037051.2016.1182856

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

27195820

1 reference

11 May 2018